|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Owonikoko TK, Ragin CC, Belani CP, Oton
AB, Gooding WE, Taioli E and Ramalingam SS: Lung cancer in elderly
patients: an analysis of the surveillance, epidemiology, and end
results database. J Clin Oncol. 25:5570–5577. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackman DM and Johnson BE: Small-cell lung
cancer. Lancet. 366:1385–1396. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Péchoux C, Dunant A, Senan S, Wolfson
A, Quoix E and Faivre-Finn C: Standard-dose versus higher-dose
prophylactic cranial irradiation (PCI) in patients with
limited-stage small-cell lung cancer in complete remission after
chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC
22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical
trial. Lancet Oncol. 10:467–474. 2009. View Article : Google Scholar
|
|
5
|
Asai N, Ohkuni Y, Kaneko N, Yamaguchi E
and Kubo A: Relapsed small cell lung cancer: treatment options and
latest developments. Ther Adv Med Oncol. 6:69–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar R, Wang RA and Bagheri-Yarmand R:
Emerging roles of MTA family members in human cancers. Semin Oncol.
30:30–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xue Y, Wong J, Moreno GT, Young MK, Côté J
and Wang W: NURD, a novel complex with both ATP-dependent
chromatin-remodeling and histone deacetylase activities. Mol Cell.
2:851–861. 1998. View Article : Google Scholar
|
|
9
|
Jang KS, Paik SS, Chung H, Oh YH and Kong
G: MTA1 overexpression correlates significantly with tumor grade
and angiogenesis in human breast cancers. Cancer Sci. 97:374–379.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li SH, Wang Z and Liu XY:
Metastasis-associated protein 1 (MTA1) overexpression is closely
associated with shorter disease-free interval after complete
resection of histologically node-negative esophageal cancer. World
J Surg. 33:1876–1881. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawasaki G, Yanamoto S, Yoshitomi I,
Yamada S and Mizuno A: Overexpression of metastasis-associated MTA1
in oral squamous cell carcinomas: correlation with metastasis and
invasion. Int J Oral Maxillofac Surg. 37:1039–1046. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Higashijima J, Kurita N, Miyatani T,
Yoshikawa K, Morimoto S, Nishioka M, Iwata T and Shimada M:
Expression of histone deacetylase 1 and metastasis-associated
protein 1 as prognostic factors in colon cancer. Oncol Rep.
26:343–348. 2011.PubMed/NCBI
|
|
13
|
Zhu X, Guo Y, Li X, Ding Y and Chen L:
Metastasis-associated protein 1 nuclear expression is associated
with tumor progression and clinical outcome in patients with
non-small cell lung cancer. J Thorac Oncol. 5:1159–1166. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li DQ, Pakala SB, Nair SS, Eswaran J and
Kumar R: Metastasis-associated protein 1/nucleosome remodeling and
histone deacetylase complex in cancer. Cancer Res. 72:387–394.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian LL, Yue W, Zhu F, Li S and Li W:
Human mesenchymal stem cells play a dual role on tumor cell growth
in vitro and in vivo. J Cell Physiol. 226:1860–1867. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qian H, Lu N, Xue L, Liang X, Zhang X, Fu
M, et al: Reduced MTA1 expression by RNAi inhibits in vitro
invasion and migration of esophageal squamous cell carcinoma cell
line. Clin Exp Metastasis. 22:653–662. 2005. View Article : Google Scholar
|
|
17
|
Wang H, Zhang D, Wu W, Zhang J, Guo D,
Wang Q, et al: Overexpression and gender-specific differences of
SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung
cancer: an in vivo study. J Histochem Cytochem. 58:1121–1127. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rudin CM, Durinck S, Stawiski EW, Poirier
JT, Modrusan Z, Shames DS, et al: Comprehensive genomic analysis
identifies SOX2 as a frequently amplified gene in small-cell lung
cancer. Nat Genet. 44:1111–1116. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sidransky D: Emerging molecular markers of
cancer. Nat Rev Cancer. 2:210–219. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Toh Y, Pencil SD and Nicolson GL: A novel
candidate metastasis-associated gene, mta1, differentially
expressed in highly metastatic mammary adenocarcinoma cell lines.
cDNA cloning, expression, and protein analyses. J Biol Chem.
269:22958–22963. 1994.PubMed/NCBI
|
|
21
|
Toh Y, Oki E, Oda S, Tokunaga E, Ohno S,
Maehara Y, Nicolson GL and Sugimachi K: Overexpression of the MTA1
gene in gastrointestinal carcinomas: correlation with invasion and
metastasis. Int J Cancer. 74:459–463. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Toh Y and Nicolson GL: The role of the MTA
family and their encoded proteins in human cancers: molecular
functions and clinical implications. Clin Exp Metastasis.
26:215–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sasaki H, Moriyama S, Nakashima Y,
Kobayashi Y, Yukiue H, Kaji M, Fukai I, Kiriyama M, Yamakawa Y and
Fujii Y: Expression of the MTA1 mRNA in advanced lung cancer. Lung
Cancer. 35:149–154. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu L, Mao XY, Fan CF and Zheng HC: MTA1
expression correlates significantly with cigarette smoke in
non-small cell lung cancer. Virchows Arch. 459:415–422. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu X, Zhang X, Wang H, Song Q, Zhang G,
Yang L, et al: MTA1 gene silencing inhibits invasion and alters the
microRNA expression profile of human lung cancer cells. Oncol Rep.
28:218–224. 2012.PubMed/NCBI
|
|
26
|
Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B
and Chen Y: Down-regulation of miR-30c promotes the invasion of
non-small cell lung cancer by targeting MTA1. Cell Physiol Biochem.
32:476–485. 2012. View Article : Google Scholar
|
|
27
|
Li S, Tian H, Yue W, Li L, Gao C, Si L, Li
W, Hu W, Qi L and Lu M: Down-regulation of MTA1 protein leads to
the inhibition of migration, invasion, and angiogenesis of
non-small-cell lung cancer cell line. Acta Biochim Biophys Sin
(Shanghai). 45:115–122. 2013. View Article : Google Scholar
|
|
28
|
Li Y, Chao Y, Fang Y, Wang J, Wang M,
Zhang H, Ying M, Zhu X and Wang H: MTA1 promotes the invasion and
migration of non-small cell lung cancer cells by downregulating
miR-125b. J Exp Clin Cancer Res. 32–33. 2003.
|
|
29
|
Nicolson GL, Nawa A, Toh Y, Taniguchi S,
Nishimori K and Moustafa A: Tumor metastasis-associated human MTA1
gene and its MTA1 protein product: role in epithelial cancer cell
invasion, proliferation and nuclear regulation. Clin Exp
Metastasis. 20:19–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qian H, Yu J, Li Y, Wang H, Song C, Zhang
X, Liang X, Fu M and Lin C: RNA interference of
metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma
cells in a C57BL/6 mouse model. Biol Cell. 99:573–581. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang H, Stephens LC and Kumar R:
Metastasis tumor antigen family proteins during breast cancer
progression and metastasis in a reliable mouse model for human
breast cancer. Clin Cancer Res. 12:1479–1486. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pakala SB, Singh K, Reddy SD, Ohshiro K,
Li DQ, Mishra L and Kumar R: TGF-β1 signaling targets
metastasis-associated protein 1, a new effector in epithelial
cells. Oncogene. 30:2230–2241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moon HE, Cheon H and Lee MS:
Metastasis-associated protein 1 inhibits p53-induced apoptosis.
Oncol Rep. 18:1311–1314. 2007.PubMed/NCBI
|
|
36
|
Kai L, Samuel SK and Levenson AS:
Resveratrol enhances p53 acetylation and apoptosis in prostate
cancer by inhibiting MTA1/ NuRD complex. Int J Cancer.
126:1538–1548. 2010.
|
|
37
|
Schmidt DR and Schreiber SL: Molecular
association between ATR and two components of the nucleosome
remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry.
38:14711–1477. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chou DM, Adamson B, Dephoure NE, Tan X,
Nottke AC, Hurov KE, Gygi SP, Colaiácovo MP and Elledge SJ: A
chromatin localization screen reveals poly (ADP ribose)-regulated
recruitment of the repressive polycomb and NuRD complexes to sites
of DNA damage. Proc Natl Acad Sci USA. 107:18475–1880. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bagheri-Yarmand R, Talukder AH, Wang RA,
Vadlamudi RK and Kumar R: Metastasis-associated protein 1
deregulation causes inappropriate mammary gland development and
tumorigenesis. Development. 131:3469–3479. 2004. View Article : Google Scholar : PubMed/NCBI
|
